Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GLGC Gene Logic -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (31)	1/25/1999 6:15:00 PM
From: Steve Lokness	Read Replies (1) \| Respond to of 360

Mike; Stay right here! Your questions are perfect for understanding the potential of GLGC and others like it. Your questions are starting to leave me in the dust, but the relavancy of them is right on target I think. Steve Push - come to our rescue. "What I worry about is that these genomic companies are going to rush in and find a whole gaggle of new lead compounds--" That is something to worry about? If you are a strong believer in the importance of SNP's you might take a look at CRGN as they have recently announced finding a passel of them. They are similar to GLGC I believe. How will GLGC use their flow through chip? GLGC just recently made the announcement of the agreement with AFFX to use their (AFFX) chip and so I wonder what GLGC plans is the market/use for the flow through chip. Thanks Mike for your comments; Steve